Indian drug and medical services startup PharmEasy has withdrawn the draft red herring prospectus (DRHP) it filed for its initial public offering (IPO) while Koye Pharmaceuticals has hired investment bank o3 Capital for a fresh fundraise.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
